Tokyo, Oct. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063403) titled 'A multi-institutional retrospective study on the clinicopathological characteristics and prognosis of uterine mesonephric-like adenocarcinoma in Japan' on Oct. 25.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Gynecologic Oncology Group
Condition:
Condition - Endometrial cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Elucidation of the clinicopathological characteristics and oncological prognosis of uterine mesonephric-like adenocarcinoma in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - (1) Patients whose initial treatment began between January 1, 1990, and September 30, 2026.
(2) Patients pathologically diagnosed with uterine mesonephric-like adenocarcinoma at each facility (regardless of whether a hysterectomy was performed).
Key exclusion criteria - Patients meeting any of the following criteria will be excluded.
(1) Patients for whom the slides or formalin-fixed paraffin-embedded blocks used for pathological diagnosis are not preserved, making central pathological diagnosis difficult.
(2) Patients whom the principal investigator or co-investigator deems ineligible for registration in this study.
Target Size - 120
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 10 Month 20 Day
Anticipated trial start date - 2027 Year 01 Month 04 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072568
Disclaimer: Curated by HT Syndication.
